Matthieu Lafon - Publications

Affiliations: 
Collège de France CNRS, Paris, Île-de-France, France 
Area:
spatial memory, kinaesthesia, egocentric, allocentric, memory

5/246 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Kolev OI, Lafon M, Zanelli G, Berthoz A. Asymmetrical Loading during Non-Visual Navigation. Neuroscience Letters. PMID 24513298 DOI: 10.1016/J.Neulet.2013.10.042  0.43
2013 Kolev OI, Lafon M, Zanelli G, Berthoz A. Asymmetrical loading during non-visual navigation. Neuroscience Letters. 557: 138-42. PMID 24466596  0.404
2009 Lafon M, Vidal M, Berthoz A. Selective influence of prior allocentric knowledge on the kinesthetic learning of a path. Experimental Brain Research. 194: 541-52. PMID 19229527 DOI: 10.1007/S00221-009-1728-2  0.465
2008 Wiener JM, Lafon M, Berthoz A. Path planning under spatial uncertainty. Memory & Cognition. 36: 495-504. PMID 18491490 DOI: 10.3758/Mc.36.3.495  0.364
2008 Lafon M, Tonnoir S, Berthoz A, Thibault G. Preparation and realization of industrial radiography for the non destructive testing of welds in Nuclear Power Plants: A spatial cognition analysis | Analyse de la préparation et de la réalisation des tirs radiographiques pour le contrôle non destructif des soudures en Centre Nucléaire de Production d'Ilectricité sous l'angle de la cognition spatiale Radioprotection. 43: 409-428. DOI: 10.1051/radiopro:2008010  0.325
Low-probability matches (unlikely to be authored by this person)
2001 Neau D, Trimoulet P, Winnock M, Le Bail B, Schvoerer E, Legrand E, Ragnaud JM, Dupon M, Fleury H, Lafon ME. Impact of protease inhibitors on intrahepatic hepatitis C virus viral load. Aids (London, England). 15: 1736-8. PMID 11546953  0.146
2006 Bonnet F, Jouvencel AC, Parrens M, Leon MJ, Cotto E, Garrigue I, Morlat P, Beylot J, Fleury H, Lafon ME. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 36: 258-63. PMID 16762591 DOI: 10.1016/j.jcv.2006.04.005  0.131
2005 Lafon M. Bat rabies--the Achilles heel of a viral killer? Lancet. 366: 876-7. PMID 16153999 DOI: 10.1016/S0140-6736(05)67297-2  0.13
1999 Follézou JY, Lan NY, Lien TX, Lafon ME, Tram LT, Hung PV, Aknine X, Lowenstein W, Ngai NV, Theodorou I, Delfraissy JF, Debré P, Fleury HJ, Barré-Sinoussi F, Chi NH. Clinical and biological characteristics of human immunodeficiency virus-infected and uninfected intravascular drug users in Ho Chi Minh City, Vietnam. The American Journal of Tropical Medicine and Hygiene. 61: 420-4. PMID 10497983  0.128
1993 Lafon ME, Gendrault JL, Royer C, Jaeck D, Kirn A, Steffan AM. Human endothelial cells isolated from the hepatic sinusoids and the umbilical vein display a different permissiveness for HIV1. Research in Virology. 144: 99-104. PMID 8446785 DOI: 10.1016/S0923-2516(06)80018-X  0.125
1996 Steffan AM, Lafon ME, Gendrault JL, Smedsrød B, Nonnenmacher H, Koehren F, Gut JP, de Monte M, Martin JP, Royer C, Kirn A. Productive infection of primary cultures of endothelial cells from the cat liver sinusoid with the feline immunodeficiency virus. Hepatology (Baltimore, Md.). 23: 964-70. PMID 8621176 DOI: 10.1002/Hep.510230504  0.125
2008 Neau D, Trimoulet P, Pereira E, Lafon ME, Gervais A, Ragnaud JM, Dupon M, Ecobichon JL, Chêne G, Raffi F. Evolution of plasma hepatitis C virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing antiretroviral regimen, Agence Nationale de Recherches sur le SIDA CO8 APROCO-COPILOTE cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 48: 227-9. PMID 18520685 DOI: 10.1097/QAI.0b013e31816d9cc3  0.124
1992 Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D, Lotteau V, Scott-Algara D. Evidence for a viral superantigen in humans. Nature. 358: 507-10. PMID 1386410 DOI: 10.1038/358507a0  0.123
2008 Lafon ME. Spread and local modification of West Nile virus in United States | Aux États-Unis, le virus West Nile s'étend et s'américanise Virologie. 12: 144-145.  0.122
1997 Dubois V, Dutronc H, Lafon ME, Poinsot V, Pellegrin JL, Ragnaud JM, Ferrer AM, Fleury HJ. Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients. Journal of Clinical Microbiology. 35: 2288-92. PMID 9276404  0.121
2008 Garrigue I, Doussau A, Asselineau J, Bricout H, Couzi L, Rio C, Merville P, Fleury H, Lafon ME, Thiébaut R. Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients. Journal of Clinical Microbiology. 46: 493-8. PMID 18057128 DOI: 10.1128/Jcm.01499-07  0.12
1998 Thoulouze MI, Lafage M, Schachner M, Hartmann U, Cremer H, Lafon M. The neural cell adhesion molecule is a receptor for rabies virus. Journal of Virology. 72: 7181-90. PMID 9696812 DOI: 10.1128/Jvi.72.9.7181-7190.1998  0.119
2005 Castellanos JE, Martïnez-Gutierrez M, Hurtado H, Kassis R, Bourhy H, Acosta O, Lafon M. Studying neurotrophin antiviral effect on rabies-infected dorsal root ganglia cultures. Journal of Neurovirology. 11: 403-10. PMID 16162483 DOI: 10.1080/13550280500187252  0.118
2002 Lafon M, Jouvin-Marche E, Marche PN, Perron H. Human viral superantigens: to be or not to be transactivated? Trends in Immunology. 23: 238-9; author reply . PMID 12102742 DOI: 10.1016/S1471-4906(02)02207-X  0.117
2000 Lafon M. [Viral superantigens]. La Revue De Mã©Decine Interne / Fondã©E ... Par La Sociã©Tã© Nationale Francaise De Mã©Decine Interne. 21: 713-6. PMID 10989504 DOI: 10.1016/S0248-8663(00)80034-X  0.114
1992 Lafon ME, Kirn A. Human immunodeficiency virus infection of the liver. Seminars in Liver Disease. 12: 197-204. PMID 1636121 DOI: 10.1055/s-2007-1007391  0.114
1995 Martinez-Arends A, Astoul E, Lafage M, Lafon M. Activation of human tonsil lymphocytes by rabies virus nucleocapsid superantigen. Clinical Immunology and Immunopathology. 77: 177-84. PMID 7586725  0.112
2003 Neau D, Jouvencel AC, Legrand E, Trimoulet P, Galperine T, Chitty I, Ventura M, Le Bail B, Morlat P, Lacut JY, Ragnaud JM, Dupon M, Fleury H, Lafon ME. Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients. Journal of Medical Virology. 71: 41-8. PMID 12858407 DOI: 10.1002/jmv.10451  0.111
2011 Lafon M. Evasive strategies in rabies virus infection. Advances in Virus Research. 79: 33-53. PMID 21601041 DOI: 10.1016/B978-0-12-387040-7.00003-2  0.111
2004 Lafon M. Subversive neuroinvasive strategy of rabies virus. Archives of Virology. Supplementum. 149-59. PMID 15119770  0.111
1992 Steffan AM, Lafon ME, Gendrault JL, Schweitzer C, Royer C, Jaeck D, Arnaud JP, Schmitt MP, Aubertin AM, Kirn A. Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the United States of America. 89: 1582-6. PMID 1371878 DOI: 10.1073/Pnas.89.5.1582  0.11
1997 Thoulouze MI, Lafage M, Montano-Hirose JA, Lafon M. Rabies virus infects mouse and human lymphocytes and induces apoptosis. Journal of Virology. 71: 7372-80. PMID 9311815  0.108
2005 Neau D, Winnock M, Jouvencel AC, Faure M, Castéra L, Legrand E, Lacoste D, Ragnaud JM, Dupon M, Fleury H, Lafon ME, Dabis F. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 750-3. PMID 15714424 DOI: 10.1086/427882  0.107
1992 Bourhy H, Kissi B, Lafon M, Sacramento D, Tordo N. Antigenic and molecular characterization of bat rabies virus in Europe. Journal of Clinical Microbiology. 30: 2419-26. PMID 1401009  0.106
2006 Jouvencel AC, Neau D, Faure M, Neau M, Martinaud C, Legrand E, Trimoulet P, Garrigue I, Le Bail B, Bioulac-Sage P, Dupon M, Ragnaud JM, Fleury H, Lafon ME. Plasma and liver hepatitis C virus variability in patients coinfected with human immunodeficiency virus. Journal of Clinical Microbiology. 44: 1877-80. PMID 16672429 DOI: 10.1128/JCM.44.5.1877-1880.2006  0.105
1996 Bourdarias B, Perro G, Cutillas M, Castede JC, Lafon ME, Sanchez R. Herpes simplex virus infection in burned patients: epidemiology of 11 cases. Burns : Journal of the International Society For Burn Injuries. 22: 287-90. PMID 8781721  0.105
1989 Bourhy H, Tordo N, Lafon M, Sureau P. Complete cloning and molecular organization of a rabies-related virus, Mokola virus. The Journal of General Virology. 70: 2063-74. PMID 2769229  0.104
2009 Amiel C, Legoff J, Lescure FX, Coste-Burel M, Deback C, Fafi-Kremer S, Gueudin M, Lafon ME, Leruez-Ville M, Mengelle C, Payan C, Pillet S. Epstein-Barr virus load in whole blood correlates with HIV surrogate markers and lymphoma: a French national cross-sectional study. Journal of Acquired Immune Deficiency Syndromes (1999). 50: 427-9. PMID 19322036 DOI: 10.1097/Qai.0B013E31819A22Ec  0.104
1993 Lafon M. Rabies virus superantigen. Research in Immunology. 144: 209-13. PMID 8235045  0.103
1994 Steffan AM, Lafon ME, Gendrault JL, Koehren F, De Monte M, Royer C, Kirn A, Gut JP. Feline immunodeficiency virus can productively infect cultured endothelial cells from cat brain microvessels. The Journal of General Virology. 75: 3647-53. PMID 7996160 DOI: 10.1099/0022-1317-75-12-3647  0.103
2008 Lafon M. Immune evasion, a critical strategy for rabies virus. Developments in Biologicals. 131: 413-9. PMID 18634503  0.102
2008 Pitard V, Roumanes D, Lafarge X, Couzi L, Garrigue I, Lafon ME, Merville P, Moreau JF, Déchanet-Merville J. Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection. Blood. 112: 1317-24. PMID 18539896 DOI: 10.1182/blood-2008-01-136713  0.102
1992 Lafon ME, Steffan AM, Gendrault JL, Klein-Soyer C, Gloeckler-Tondre L, Royer C, Kirn A. Interaction of human immunodeficiency virus with human macrovascular endothelial cells in vitro. Aids Research and Human Retroviruses. 8: 1567-70. PMID 1457202 DOI: 10.1089/Aid.1992.8.1567  0.1
2007 Mégret F, Prehaud C, Lafage M, Moreau P, Rouas-Freiss N, Carosella ED, Lafon M. Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. Human Immunology. 68: 294-302. PMID 17400066 DOI: 10.1016/j.humimm.2006.12.003  0.1
1983 Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, Smith CL, Koprowski H. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proceedings of the National Academy of Sciences of the United States of America. 80: 70-4. PMID 6185960 DOI: 10.1073/pnas.80.1.70  0.099
2003 Thoulouze MI, Lafage M, Yuste VJ, Baloul L, Edelman L, Kroemer G, Israel N, Susin SA, Lafon M. High level of Bcl-2 counteracts apoptosis mediated by a live rabies virus vaccine strain and induces long-term infection. Virology. 314: 549-61. PMID 14554083 DOI: 10.1016/S0042-6822(03)00491-4  0.098
2007 Lafon ME. Herpesvirus-specific CD8 T cell immunity in old age: Cytomegalovirus impairs the response to a coresident EBV infection | Le CMV encombre le système immunitaire des personnes âgées Virologie. 11: 256-257. DOI: 10.1684/vir.2007.0094  0.097
1990 Lafon M, Edelman L, Bouvet JP, Lafage M, Montchâtre E. Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein. The Journal of General Virology. 71: 1689-96. PMID 2391499  0.097
2015 Caillet-Saguy C, Maisonneuve P, Delhommel F, Terrien E, Babault N, Lafon M, Cordier F, Wolff N. Strategies to interfere with PDZ-mediated interactions in neurons: What we can learn from the rabies virus. Progress in Biophysics and Molecular Biology. PMID 25748547 DOI: 10.1016/j.pbiomolbio.2015.02.007  0.096
2003 Cotto E, Neau D, Cransac-Neau M, Auriacombe M, Pellegrin JL, Ragnaud JM, Fillet AM, Belnard M, Fleury H, Lafon ME. Borna disease virus RNA in immunocompromised patients in southwestern France. Journal of Clinical Microbiology. 41: 5577-81. PMID 14662943 DOI: 10.1128/Jcm.41.12.5577-5581.2003  0.096
2011 Chopy D, Detje CN, Lafage M, Kalinke U, Lafon M. The type I interferon response bridles rabies virus infection and reduces pathogenicity. Journal of Neurovirology. 17: 353-67. PMID 21805057 DOI: 10.1007/s13365-011-0041-6  0.095
2010 Burrel S, Dilhuydy S, Bouabdallah K, Lafon MÉ, Milpied N, Fleury H. [Persistent influenza virus infection in a patient treated with alemtuzumab]. Mã©Decine Et Maladies Infectieuses. 40: 657-9. PMID 20638206 DOI: 10.1016/j.medmal.2010.03.001  0.094
2001 Dubois V, Moret H, Lafon ME, Brodard V, Icart J, Ruffault A, Guist'hau O, Buffet-Janvresse C, Abbed K, Dussaix E, Ingrand D. JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy. The Journal of Infectious Diseases. 183: 213-217. PMID 11110646 DOI: 10.1086/317927  0.092
1987 Dietzschold B, Tollis M, Lafon M, Wunner WH, Koprowski H. Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies. Virology. 161: 29-36. PMID 3672933 DOI: 10.1016/0042-6822(87)90167-X  0.092
1998 Lafon ME, Dutronc H, Dubois V, Pellegrin I, Barbeau P, Ragnaud JM, Pellegrin JL, Fleury HJ. JC virus remains latent in peripheral blood B lymphocytes but replicates actively in urine from AIDS patients. The Journal of Infectious Diseases. 177: 1502-5. PMID 9607826  0.092
1986 Lafon M, Herzog M, Sureau P. Human rabies vaccines induce neutralising antibodies against the European bat rabies virus (Duvenhage) Lancet. 2: 515. PMID 2875263  0.092
2005 Lafon M. Modulation of the immune response in the nervous system by rabies virus. Current Topics in Microbiology and Immunology. 289: 239-58. PMID 15791959  0.091
2014 Si-Tahar M, Blanc F, Furio L, Chopy D, Balloy V, Lafon M, Chignard M, Fiette L, Langa F, Charneau P, Pothlichet J. Protective role of LGP2 in influenza virus pathogenesis. The Journal of Infectious Diseases. 210: 214-23. PMID 24493823 DOI: 10.1093/infdis/jiu076  0.09
2004 Neau D, Winnock M, Galpérine T, Jouvencel AC, Castéra L, Legrand E, Tranchant E, Balestre E, Lacoste D, Ragnaud JM, Dupon M, Lafon ME, Dabis F. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. Hiv Medicine. 5: 171-3. PMID 15139983 DOI: 10.1111/J.1468-1293.2004.00206.X  0.09
2005 Lafon M, Prehaud C, Megret F, Lafage M, Mouillot G, Roa M, Moreau P, Rouas-Freiss N, Carosella ED. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. Journal of Virology. 79: 15226-37. PMID 16306594 DOI: 10.1128/JVI.79.24.15226-15237.2005  0.089
2000 Galelli A, Baloul L, Lafon M. Abortive rabies virus central nervous infection is controlled by T lymphocyte local recruitment and induction of apoptosis. Journal of Neurovirology. 6: 359-72. PMID 11031689  0.089
2008 Lafon M, Mégret F, Meuth SG, Simon O, Velandia Romero ML, Lafage M, Chen L, Alexopoulou L, Flavell RA, Prehaud C, Wiendl H. Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis. Journal of Immunology (Baltimore, Md. : 1950). 180: 7506-15. PMID 18490751 DOI: 10.4049/Jimmunol.180.11.7506  0.088
2005 Seydi M, Morlat P, Bonnet F, Rambeloarisoa J, Bernard N, Lacoste D, Bonarek M, Trimoulet P, Ramanampamonjy R, Lafon ME, Dramé M, Beylot J. [Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up]. La Revue De Mã©Decine Interne / Fondã©E ... Par La Sociã©Tã© Nationale Francaise De Mã©Decine Interne. 26: 280-7. PMID 15820563 DOI: 10.1016/j.revmed.2004.11.022  0.088
1994 Lafon ME, Steffan AM, Royer C, Jaeck D, Beretz A, Kirn A, Gendrault JL. HIV-1 infection induces functional alterations in human liver endothelial cells in primary culture. Aids (London, England). 8: 747-52. PMID 8086131 DOI: 10.1097/00002030-199406000-00004  0.087
2015 Hohenberger M, Radha PB, Myatt JF, Lepape S, Marozas JA, Marshall FJ, Michel DT, Regan SP, Seka W, Shvydky A, Sangster TC, Bates JW, Betti R, Boehly TR, Bonino MJ, ... ... Lafon M, et al. Polar-direct-drive experiments on the National Ignition Facility Physics of Plasmas. 22. DOI: 10.1063/1.4920958  0.087
2003 Baloul L, Lafon M. Apoptosis and rabies virus neuroinvasion. Biochimie. 85: 777-88. PMID 14585545  0.086
2003 Préhaud C, Lay S, Dietzschold B, Lafon M. Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis. Journal of Virology. 77: 10537-47. PMID 12970438  0.086
1998 Dubois V, Moret H, Lafon ME, Janvresse CB, Dussaix E, Icart J, Karaterki A, Ruffault A, Taoufik Y, Vignoli C, Ingrand D. Prevalence of JC virus viraemia in HIV-infected patients with or without neurological disorders: a prospective study. Journal of Neurovirology. 4: 539-44. PMID 9839651  0.086
2008 Piroth L, Lafon ME, Binquet C, Bertillon P, Gervais A, Lootvoet E, Lang JM, De Jaureguiberry JP, Chene G, Leport C. Occult hepatitis B in HIV-HCV coinfected patients. Scandinavian Journal of Infectious Diseases. 40: 835-9. PMID 18609222 DOI: 10.1080/00365540801918511  0.085
2005 Préhaud C, Mégret F, Lafage M, Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. Journal of Virology. 79: 12893-904. PMID 16188991 DOI: 10.1128/JVI.79.20.12893-12904.2005  0.085
1988 Dietzschold B, Rupprecht CE, Tollis M, Lafon M, Mattei J, Wiktor TJ, Koprowski H. Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Reviews of Infectious Diseases. 10: S785-98. PMID 3206089 DOI: 10.1093/clinids/10.Supplement_4.S785  0.084
2007 Masquelier B, Capdepont S, Neau D, Peuchant O, Taupin JL, Coakley E, Lie Y, Carpentier W, Dabis F, Fleury HJA, Beylot J, Dupon M, Longy-Boursier M, Pellegrin JL, Ragnaud JM, ... ... Lafon ME, et al. Virological characterization of an infection with a dual-tropic, multidrug-resistant HIV-1 and further evolution on antiretroviral therapy Aids. 21: 103-106. PMID 17148975 DOI: 10.1097/Qad.0B013E3280117053  0.084
2009 Pistone T, Ezzedine K, Boisvert M, Receveur MC, Schuffenecker I, Zeller H, Lafon ME, Fleury H, Malvy D. Cluster of chikungunya virus infection in travelers returning from Senegal, 2006. Journal of Travel Medicine. 16: 286-8. PMID 19674271 DOI: 10.1111/j.1708-8305.2008.00294.x  0.084
1985 Wunner WH, Dietzschold B, Smith CL, Lafon M, Golub E. Antigenic variants of CVS rabies virus with altered glycosylation sites. Virology. 140: 1-12. PMID 3966297  0.083
1984 Lafon M, Ideler J, Wunner WH. Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies. Developments in Biological Standardization. 57: 219-25. PMID 6084612  0.083
2007 Lafon ME. HV8 diversity and pathogenesis | Variabilité du HHV8 et pouvoir pathogène: Une critique constructive Virologie. 11: 395-396.  0.083
2004 Baloul L, Camelo S, Lafon M. Up-regulation of Fas ligand (FasL) in the central nervous system: a mechanism of immune evasion by rabies virus. Journal of Neurovirology. 10: 372-82. PMID 15765808 DOI: 10.1080/13550280490521122  0.082
1994 Scott-Algara D, Lafon M, Vuillier F, Pialoux G, Dauguet C, Dighiero G. Viral superantigen-induced hyporesponsiveness of T cells and polyclonal B cell activation in HIV-1 infection. European Journal of Immunology. 24: 2595-601. PMID 7957553 DOI: 10.1002/eji.1830241105  0.082
2005 Mégret F, Prehaud C, Lafage M, Batejat C, Escriou N, Lay S, Thoulouze MI, Lafon M. Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis. Vaccine. 23: 5342-50. PMID 16054731 DOI: 10.1016/j.vaccine.2005.06.027  0.081
2003 Thoulouze MI, Lafage M, Yuste VJ, Kroemer G, Susin SA, Israel N, Lafon M. Apoptosis inversely correlates with rabies virus neurotropism. Annals of the New York Academy of Sciences. 1010: 598-603. PMID 15033799 DOI: 10.1196/Annals.1299.112  0.081
2007 Neau D, Winnock M, Castéra L, Bail BL, Loko MA, Géraut L, Dupon M, Ragnaud JM, Lacoste D, Lafon ME, Bioulac-Sage P, Dabis F. Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 45: 168-73. PMID 17527092 DOI: 10.1097/Qai.0B013E318042E1Db  0.081
2005 Lafon M. Rabies virus receptors. Journal of Neurovirology. 11: 82-7. PMID 15804965 DOI: 10.1080/13550280590900427  0.081
2014 Luz PM, Bruyand M, Ribeiro S, Bonnet F, Moreira RI, Hessamfar M, Campos DP, Greib C, Cazanave C, Veloso VG, Dabis F, Grinsztejn B, Chêne G, Breilh D, Dupon M, ... ... Lafon ME, et al. AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: Hospital-based cohort studies Bmc Infectious Diseases. 14. PMID 24885790 DOI: 10.1186/1471-2334-14-278  0.081
2011 Chopy D, Pothlichet J, Lafage M, Mégret F, Fiette L, Si-Tahar M, Lafon M. Ambivalent role of the innate immune response in rabies virus pathogenesis. Journal of Virology. 85: 6657-68. PMID 21525357 DOI: 10.1128/JVI.00302-11  0.08
2009 Terrien E, Simenel C, Prehaud C, Buc H, Delepierre M, Lafon M, Wolff N. 1H, 13C and 15N resonance assignments of the PDZ of microtubule-associated serine/threonine kinase 205 (MAST205) in complex with the C-terminal motif from the rabies virus glycoprotein. Biomolecular Nmr Assignments. 3: 45-8. PMID 19636944 DOI: 10.1007/s12104-008-9138-0  0.08
1988 Lafon M, Bourhy H, Sureau P. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice. Vaccine. 6: 362-8. PMID 2461007  0.079
1987 Lafon M, Lafage M. Antiviral activity of monoclonal antibodies specific for the internal proteins N and NS of rabies virus. The Journal of General Virology. 68: 3113-23. PMID 2447223  0.079
1985 Lafon M, Wiktor TJ. Antigenic sites on the ERA rabies virus nucleoprotein and non-structural protein. The Journal of General Virology. 66: 2125-33. PMID 2413164  0.077
2009 Lafon M. Latent viral infections of the nervous system: role of the host immune response. Revue Neurologique. 165: 1039-44. PMID 19906390 DOI: 10.1016/j.neurol.2009.09.010  0.077
1984 Libeau G, Lafon M, Rollin PE. [Specificity of monoclonal antibodies obtained with the Paster PV rabies virus strain]. Revue D'ã©Levage Et De Mã©Decine Vã©Tã©Rinaire Des Pays Tropicaux. 37: 383-94. PMID 6400350  0.077
2004 Danve-Szatanek C, Aymard M, Thouvenot D, Morfin F, Agius G, Bertin I, Billaudel S, Chanzy B, Coste-Burel M, Finkielsztejn L, Fleury H, Hadou T, Henquell C, Lafeuille H, Lafon ME, et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. Journal of Clinical Microbiology. 42: 242-9. PMID 14715760 DOI: 10.1128/Jcm.42.1.242-249.2004  0.077
1996 Dubois V, Lafon ME, Ragnaud JM, Pellegrin JL, Damasio F, Baudouin C, Michaud V, Fleury HJ. Detection of JC virus DNA in the peripheral blood leukocytes of HIV-infected patients. Aids (London, England). 10: 353-8. PMID 8728037  0.077
1983 Lafon M, Wiktor TJ, Macfarlan RI. Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. The Journal of General Virology. 64: 843-51. PMID 6834008  0.076
1987 Dietzschold B, Lafon M, Wang H, Otvos L, Celis E, Wunner WH, Koprowski H. Localization and immunological characterization of antigenic domains of the rabies virus internal N and NS proteins. Virus Research. 8: 103-25. PMID 2445121 DOI: 10.1016/0168-1702(87)90023-2  0.076
2009 Ménager P, Roux P, Mégret F, Bourgeois JP, Le Sourd AM, Danckaert A, Lafage M, Préhaud C, Lafon M. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. Plos Pathogens. 5: e1000315. PMID 19247444 DOI: 10.1371/journal.ppat.1000315  0.076
2003 Lay S, Préhaud C, Dietzschold B, Lafon M. Glycoprotein of nonpathogenic rabies viruses is a major inducer of apoptosis in human jurkat T cells. Annals of the New York Academy of Sciences. 1010: 577-81. PMID 15033795  0.075
2003 Neau D, Trimoulet P, Winnock M, Rullier A, Le Bail B, Lacoste D, Ragnaud JM, Bioulac-Sage P, Lafon ME, Chêne G, Dupon M. Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 36: 1564-71. PMID 12802757 DOI: 10.1086/375067  0.075
2014 Lafon M. Rabies: Neurobiology Neglected Tropical Diseases and Conditions of the Nervous System. 251-267. DOI: 10.1007/978-1-4614-8100-3_14  0.075
2007 Trimoulet P, Boutonnet M, Winnock M, Faure M, Loko MA, De Lédinghen V, Bernard PH, Castéra L, Foucher J, Dupon M, Ragnaud JM, Lafon ME, Couzigou P, Dabis F, Fleury H, et al. Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004. Gastroentã©Rologie Clinique Et Biologique. 31: 1088-94. PMID 18176363 DOI: 10.1016/S0399-8320(07)78341-0  0.074
2002 Trimoulet P, Neau D, Le Bail B, Rullier A, Winnock M, Galperine T, Legrand E, Schvoerer E, Dupon M, Ragnaud JM, Bioulac-Sage P, Chêne G, Fleury H, Lafon ME. Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection. Journal of Medical Virology. 67: 143-51. PMID 11992575 DOI: 10.1002/jmv.2203  0.074
1994 Lafon M, Scott-Algara D, Marche PN, Cazenave PA, Jouvin-Marche E. Neonatal deletion and selective expansion of mouse T cells by exposure to rabies virus nucleocapsid superantigen. The Journal of Experimental Medicine. 180: 1207-15. PMID 7931058  0.074
2003 Viallard JF, Parrens M, Hermine O, Boiron JM, Lafon ME, Marit G, Reiffers J, Pellegrin JL. Severe prolonged red blood cell aplasia and thrombocytopenia induced by parvovirus B19 infection in a patient with sarcoidosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 36: 229-33. PMID 12522758 DOI: 10.1086/345745  0.074
1984 Sureau P, Rollin P, Lafon M. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies. Developments in Biological Standardization. 57: 227-31. PMID 6084613  0.073
2006 Jackson AC, Rossiter JP, Lafon M. Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. Journal of Neurovirology. 12: 229-34. PMID 16877304 DOI: 10.1080/13550280600848399  0.073
2010 Préhaud C, Wolff N, Terrien E, Lafage M, Mégret F, Babault N, Cordier F, Tan GS, Maitrepierre E, Ménager P, Chopy D, Hoos S, England P, Delepierre M, Schnell MJ, ... ... Lafon M, et al. Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Science Signaling. 3: ra5. PMID 20086240 DOI: 10.1126/Scisignal.2000510  0.073
2010 Faure G, Chapuis O, Lafon MB. Depth perception in window management | Perception de la profondeur en gestion de fenêtres Ihm'10 - 22nd Conference Francophone Sur L'Interaction Homme-Machine. 149-152.  0.072
1999 Schvoerer E, Bonnet F, Dubois V, Rogues AM, Gachie JP, Lafon ME, Fleury HJ. A hospital outbreak of gastroenteritis possibly related to the contamination of tap water by a small round structured virus. The Journal of Hospital Infection. 43: 149-54. PMID 10549314 DOI: 10.1053/jhin.1999.0632  0.071
2009 Lafon ME. The mask of the Black Death | Le masque de la Mort Noire Virologie. 13: 117.  0.07
1990 Hirose JA, Bourhy H, Lafon M. A reduced panel of anti-nucleocapsid monoclonal antibodies for bat rabies virus identification in Europe. Research in Virology. 141: 571-81. PMID 2277871  0.07
2006 Lafon ME. Herd protection against influenza | Comment obtenir une protection collective contre la grippe? Virologie. 10: 457-458.  0.07
2012 Lafon M, Guaguère E. Grenelle in partnership: The AFVAC specifies its missions and remains the guarantor of its scientific independence | Grenelle du partenariat L'AFVAC précise ses missions et demeure garant de son indépendance scientifique Pratique Vet. 10-11.  0.07
2012 Terrien E, Chaffotte A, Lafage M, Khan Z, Préhaud C, Cordier F, Simenel C, Delepierre M, Buc H, Lafon M, Wolff N. Interference with the PTEN-MAST2 interaction by a viral protein leads to cellular relocalization of PTEN. Science Signaling. 5: ra58. PMID 22894835 DOI: 10.1126/scisignal.2002941  0.07
1999 Jacotot E, Cardona A, Rebouillat D, Terradillos O, Marianneau P, Thoulouze MI, Lafon M, Deubel V, Edelman L. Combined use of radioimagers and radioactive 3'OH DNA nick end labelling to quantify apoptosis in cell lines and tissue sections: applications to virus-induced apoptosis. Apoptosis : An International Journal On Programmed Cell Death. 4: 169-78. PMID 14634279 DOI: 10.1023/A:1009658522328  0.069
2008 Lafon ME. Mice and European arenaviruses | Des souris et des arenavirus européens Virologie. 12: 385-386. DOI: 10.1684/vir.2008.0191  0.069
1984 Libeau G, Lafon M. Production of monoclonal antibodies against the Pasteur (P.V.) strain of rabies virus: problems and results. Developments in Biological Standardization. 57: 213-8. PMID 6526139  0.069
1995 Montaño-Hirose JA, Lafage M, Lafon M. Measurement of rabies virus N protein in rabies vaccines. Research in Virology. 146: 217-24. PMID 7481094  0.068
2001 Camelo S, Castellanos J, Lafage M, Lafon M. Rabies virus ocular disease: T-cell-dependent protection is under the control of signaling by the p55 tumor necrosis factor alpha receptor, p55TNFR. Journal of Virology. 75: 3427-34. PMID 11238868 DOI: 10.1128/JVI.75.7.3427-3434.2001  0.067
2008 Laothamatas J, Wacharapluesadee S, Lumlertdacha B, Ampawong S, Tepsumethanon V, Shuangshoti S, Phumesin P, Asavaphatiboon S, Worapruekjaru L, Avihingsanon Y, Israsena N, Lafon M, Wilde H, Hemachudha T. Furious and paralytic rabies of canine origin: neuroimaging with virological and cytokine studies. Journal of Neurovirology. 14: 119-29. PMID 18444083 DOI: 10.1080/13550280701883857  0.067
2005 Viallard JF, Ellie E, Lazaro E, Lafon ME, Pellegrin JL. JC virus meningitis in a patient with systemic lupus erythematosus. Lupus. 14: 964-6. PMID 16425577 DOI: 10.1191/0961203305lu2229cr  0.067
2011 Lafon ME. Opportunistic adenovirus infections in hematopoietic stem cell transplantation: A possible preemptive strategy? | Infections opportunistes à adénovirus en greffe de cellules souches hématopoïétiques: Une stratégie préemptive possible? Virologie. 15: 75. DOI: 10.1684/vir.2011.0383  0.066
2001 Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, ... Lafon M, et al. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology. 287: 321-32. PMID 11531410 DOI: 10.1006/Viro.2001.1045  0.066
2008 Lafon ME. Is cell tropism dependent upon a single aminoacid residue? | Et si le tropisme cellulaire ne tenait qu'à un acide aminé? Virologie. 12: 142. DOI: 10.1684/vir.2008.0161  0.066
2002 Legrand E, Neau D, Galperine T, Trimoulet P, Moreau JF, Pitard V, Lacut JY, Ragnaud JM, Dupon M, Le Bail B, Bernard N, Schvoerer E, Houghton M, Fleury H, Lafon ME. CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment. The Journal of Infectious Diseases. 186: 302-11. PMID 12134226 DOI: 10.1086/341659  0.064
2008 Vuaillat C, Varrin-Doyer M, Bernard A, Sagardoy I, Cavagna S, Chounlamountri I, Lafon M, Giraudon P. High CRMP2 expression in peripheral T lymphocytes is associated with recruitment to the brain during virus-induced neuroinflammation. Journal of Neuroimmunology. 193: 38-51. PMID 18006081 DOI: 10.1016/j.jneuroim.2007.09.033  0.061
2006 Lafon M, Megret F, Lafage M, Prehaud C. The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. Journal of Molecular Neuroscience : Mn. 29: 185-94. PMID 17085778 DOI: 10.1385/JMN:29:3:185  0.061
2007 Herpe B, Schuffenecker I, Pillot J, Malvy D, Clouzeau B, Bui N, Vargas F, Gruson D, Zeller H, Lafon ME, Fleury H, Hilbert G. Tickborne encephalitis, southwestern France. Emerging Infectious Diseases. 13: 1114-6. PMID 18214196 DOI: 10.3201/eid1307.070041  0.06
2000 Schvoerer E, Bonnet F, Dubois V, Cazaux G, Serceau R, Fleury HJ, Lafon ME. PCR detection of human enteric viruses in bathing areas, waste waters and human stools in Southwestern France. Research in Microbiology. 151: 693-701. PMID 11081583  0.06
2010 Pistone T, Verdière CH, Receveur MC, Ezzedine K, Lafon ME, Malvy D. Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients. Current Hiv Research. 8: 461-6. PMID 20636276  0.06
2010 Lafon ME. Adenovirus and cancer: To inactivate p53, "the belt and the straps" | Adenovirus et cancer: Pour inactiver p53, «la ceinture et les bretelles» Virologie. 14: 363-364. DOI: 10.1684/vir.2010.0322  0.06
2004 Martin K, Lawson-Ayayi S, Miremont-Salamé G, Blaizeau MJ, Balestre E, Lacoste D, Ragnaud JM, Malvy D, Dupon M, Mercié P, Schaeverbeke T, Haramburu F, Chêne G, Dabis F, Salamon R, ... ... Lafon ME, et al. Symptomatic bone disorders in HIV-infected patients: Incidence in the Aquitaine cohort (1999-2002) Hiv Medicine. 5: 421-426. PMID 15544694 DOI: 10.1111/J.1468-1293.2004.00247.X  0.059
1991 Ceballos-Picot I, Nicole A, Briand P, Grimber G, Delacourte A, Defossez A, Javoy-Agid F, Lafon M, Blouin JL, Sinet PM. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Research. 552: 198-214. PMID 1717112 DOI: 10.1016/0006-8993(91)90084-9  0.059
1992 Herzog M, Lafage M, Montaño-Hirose JA, Fritzell C, Scott-Algara D, Lafon M. Nucleocapsid specific T and B cell responses in humans after rabies vaccination. Virus Research. 24: 77-89. PMID 1626425  0.058
2015 Nora R, Theobald W, Betti R, Marshall FJ, Michel DT, Seka W, Yaakobi B, Lafon M, Stoeckl C, Delettrez J, Solodov AA, Casner A, Reverdin C, Ribeyre X, Vallet A, et al. Gigabar spherical shock generation on the OMEGA laser. Physical Review Letters. 114: 045001. PMID 25679896 DOI: 10.1103/Physrevlett.114.045001  0.058
2003 Neau D, Galpérine T, Legrand E, Pitard V, Neau-Cransac M, Moreau JF, Ragnaud JM, Dupon M, Fleury H, Lafon ME. T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin. Hiv Medicine. 4: 120-6. PMID 12702132 DOI: 10.1046/j.1468-1293.2003.00140.x  0.058
2013 Theobald W, Casner A, Nora R, Ribeyre X, Lafon M, Anderson KS, Betti R, Craxton RS, Delettrez JA, Frenje JA, Glebov VY, Gotchev OV, Hohenberger M, Hu SX, Marshall FJ, et al. Progress in the shock-ignition inertial confinement fusion concept Epj Web of Conferences. 59. DOI: 10.1051/epjconf/20135903001  0.058
1991 Herzog M, Fritzell C, Lafage M, Montaño Hirose JA, Scott-Algara D, Lafon M. T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clinical and Experimental Immunology. 85: 224-30. PMID 1864001  0.058
2012 Berciaud S, Rayne F, Kassab S, Jubert C, Faure-Della Corte M, Salin F, Wodrich H, Lafon ME. Adenovirus infections in Bordeaux University Hospital 2008-2010: clinical and virological features. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 54: 302-7. PMID 22608365 DOI: 10.1016/j.jcv.2012.04.009  0.057
2006 Castéra L, Pedeboscq A, Rocha M, Le Bail B, Asencio C, de Lédinghen V, Bernard PH, Laurent C, Lafon ME, Capdepont M, Couzigou P, Bioulac-Sage P, Balabaud C, Mégraud F, Ménard A. Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study. World Journal of Gastroenterology : Wjg. 12: 7278-84. PMID 17143941 DOI: 10.3748/Wjg.V12.I45.7278  0.057
2014 Hohenberger M, Theobald W, Hu SX, Anderson KS, Betti R, Boehly TR, Casner A, Fratanduono DE, Lafon M, Meyerhofer DD, Nora R, Ribeyre X, Sangster TC, Schurtz G, Seka W, et al. Shock-ignition relevant experiments with planar targets on OMEGA Physics of Plasmas. 21. DOI: 10.1063/1.4865373  0.057
2009 Couzi L, Pitard V, Netzer S, Garrigue I, Lafon ME, Moreau JF, Taupin JL, Merville P, Déchanet-Merville J. Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients. The Journal of Infectious Diseases. 200: 1415-24. PMID 19780672 DOI: 10.1086/644509  0.057
2013 Lafon M, Ribeyre X, Schurtz G. Optimal conditions for shock ignition of scaled cryogenic deuterium-tritium targets Physics of Plasmas. 20. DOI: 10.1063/1.4792265  0.056
2015 Lafon M, Betti R, Anderson KS, Collins TJB, Epstein R, McKenty PW, Myatt JF, Shvydky A, Skupsky S. Direct-drive-ignition designs with mid- Z ablators Physics of Plasmas. 22. DOI: 10.1063/1.4914835  0.056
2000 Camelo S, Lafage M, Lafon M. Absence of the p55 Kd TNF-alpha receptor promotes survival in rabies virus acute encephalitis. Journal of Neurovirology. 6: 507-18. PMID 11175323  0.055
1993 Montaño-Hirose JA, Lafage M, Weber P, Badrane H, Tordo N, Lafon M. Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice. Vaccine. 11: 1259-66. PMID 8256507  0.055
1991 Ceballos I, Javoy-Agid F, Delacourte A, Defossez A, Lafon M, Hirsch E, Nicole A, Sinet PM, Agid Y. Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains. Free Radical Research Communications. 12: 571-80. PMID 2060834 DOI: 10.3109/10715769109145832  0.055
2001 Camelo S, Lafage M, Galelli A, Lafon M. Selective role for the p55 Kd TNF-alpha receptor in immune unresponsiveness induced by an acute viral encephalitis. Journal of Neuroimmunology. 113: 95-108. PMID 11137581  0.054
2005 Neau-Cransac M, Foucher J, Ledinghen VD, Bernard PH, Legrand E, Lafon ME. Modifications of T-lymphocyte subsets before and during interferon and ribavirin treatment for chronic hepatitis C infection. Viral Immunology. 18: 197-204. PMID 15802964 DOI: 10.1089/vim.2005.18.197  0.053
2015 Theobald W, Nora R, Seka W, Lafon M, Anderson KS, Hohenberger M, Marshall FJ, Michel DT, Solodov AA, Stoeckl C, Edgell DH, Yaakobi B, Casner A, Reverdin C, Ribeyre X, et al. Spherical strong-shock generation for shock-ignition inertial fusion Physics of Plasmas. 22. DOI: 10.1063/1.4920956  0.053
1988 Vodopija I, Sureau P, Smerdel S, Lafon M, Baklaic Z, Ljubicic M, Svjetlicic M. Comparative study of two human diploid rabies vaccines administered with antirabies globulin. Vaccine. 6: 489-90. PMID 3245292  0.053
2012 Cordier F, Chaffotte A, Terrien E, Préhaud C, Theillet FX, Delepierre M, Lafon M, Buc H, Wolff N. Ordered phosphorylation events in two independent cascades of the PTEN C-tail revealed by NMR. Journal of the American Chemical Society. 134: 20533-43. PMID 23171049 DOI: 10.1021/ja310214g  0.053
2013 Kassab S, Saghi T, Boyer A, Lafon ME, Gruson D, Lina B, Fleury H, Schuffenecker I. Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012. Emerging Infectious Diseases. 19: 1345-7. PMID 23880543 DOI: 10.3201/eid1908.130202  0.053
2011 Babault N, Cordier F, Lafage M, Cockburn J, Haouz A, Prehaud C, Rey FA, Delepierre M, Buc H, Lafon M, Wolff N. Peptides targeting the PDZ domain of PTPN4 are efficient inducers of glioblastoma cell death. Structure (London, England : 1993). 19: 1518-24. PMID 22000519 DOI: 10.1016/j.str.2011.07.007  0.053
2007 Lewden C, Chêne G, Morlat P, Raffi F, Dupon M, Dellamonica P, Pellegrin JL, Katlama C, Dabis F, Leport C, Salamon R, Moatti JP, Pierret J, Spire B, Brun-Vézinet F, ... ... Lafon ME, et al. HIV-infected adults with a CD4 cell count greater than 500 cells/mm 3 on long-term combination antiretroviral therapy reach same mortality rates as the general population Journal of Acquired Immune Deficiency Syndromes. 46: 72-77. PMID 17621240 DOI: 10.1097/Qai.0B013E318134257A  0.052
2011 Bruyand M, Vandenhende MA, Marcel G, Lazaro E, Lafon ME, Dupon M, Dabis F, Geffard S, Fleury H, Faure-Della Corte M, Bonnet F, Thiebaut R, Garrigue I. CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 50: 177-80. PMID 21126905 DOI: 10.1016/J.Jcv.2010.10.021  0.05
1976 Vichard P, Grosdidier J, Lafon M, Arbez Gindre F, Suzanne J, Boissel P, Watelet F. [Transfixion by a bullet of the innominate vein, trachea and esophagus. Therapeutic considerations]. Chirurgie; Mã©Moires De L'Acadã©Mie De Chirurgie. 102: 235-40. PMID 791594  0.05
2003 Lan NT, Recordon-Pinson P, Hung PV, Uyen NT, Lien TT, Tien HT, Garrigue I, Schrive MH, Pellegrin I, Lafon ME, Aboulker JP, Barré-Sinousi F, Fleury HJ. HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs. Aids Research and Human Retroviruses. 19: 925-8. PMID 14601592 DOI: 10.1089/088922203322493111  0.05
2008 Garrigue I, Faure-Della Corte M, Magnin N, Recordon-Pinson P, Couzi L, Lebrette ME, Schrive MH, Roncin L, Taupin JL, Déchanet-Merville J, Fleury H, Lafon ME. UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients. Transplantation. 86: 826-35. PMID 18813108 DOI: 10.1097/TP.0b013e3181859edd  0.048
2003 Buffet-Janvresse C, Peigue-Lafeuille H, Benichou J, Vabret A, Branger M, Trimoulet P, Goria O, Laurichesse H, Abbed A, Verdon R, Bouvet E, Lafon ME, Dussaix E, Cormerais L, Dupon M, et al. HIV and HCV co-infection: situation at six French university hospitals in the year 2000. Journal of Medical Virology. 69: 7-17. PMID 12436472 DOI: 10.1002/jmv.10268  0.048
2016 Maisonneuve P, Caillet-Saguy C, Vaney MC, Edoo BZ, Sawyer K, Raynal B, Delepierre M, Lafon M, Cordier F, Wolff N. Molecular Basis of The Interaction of the Human Protein Tyrosine Phosphatase Non-receptor Type 4 (PTPN4) with the Mitogen-Activated Protein Kinase p38γ. The Journal of Biological Chemistry. PMID 27246854 DOI: 10.1074/jbc.M115.707208  0.047
2010 Bénard A, Mercié P, Alioum A, Bonnet F, Lazaro E, Dupon M, Neau D, Dabis F, Chêne G, Longy-Boursier M, Morlat P, Pellegrin JL, Ragnaud JM, Bruyand M, Lawson-Ayayi S, ... ... Lafon ME, et al. Bacterial pneumonia among HIV-infected patients: Decreased risk after tobacco smoking cessation. ANRS CO3 aquitaine cohort, 2000-2007 Plos One. 5. PMID 20126646 DOI: 10.1371/journal.pone.0008896  0.046
2006 Duffau P, Moiton MP, Lafon ME, Braun C, Neau D, Ragnaud JM. [A case of severe community acquired pneumonia and non-respiratory illness induced by Influenza A]. Mã©Decine Et Maladies Infectieuses. 36: 473-5. PMID 17027214 DOI: 10.1016/j.medmal.2006.07.004  0.046
2009 Burrel S, Roncin L, Lafon ME, Fleury H. Oseltamivir susceptibility in south-western France during the 2007-8 and 2008-9 influenza epidemics and the ongoing influenza pandemic 2009. Euro Surveillance : Bulletin Europã©En Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 14. PMID 19814958  0.045
2006 Garrigue I, Boucher S, Couzi L, Caumont A, Dromer C, Neau-Cransac M, Tabrizi R, Schrive MH, Fleury H, Lafon ME. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 36: 72-5. PMID 16481215 DOI: 10.1016/j.jcv.2006.01.002  0.045
1988 Vodopija I, Sureau P, Smerdel S, Lafon M, Baklaić Z, Ljubicić M, Svjetlicić M. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment. Vaccine. 6: 283-6. PMID 3420976  0.045
2014 Hubiche T, Schuffenecker I, Boralevi F, Léauté-Labrèze C, Bornebusch L, Chiaverini C, Phan A, Maruani A, Miquel J, Lafon ME, Lina B, Del Giudice P. Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema. The Pediatric Infectious Disease Journal. 33: e92-8. PMID 24463804 DOI: 10.1097/INF.0000000000000120  0.044
2003 Toni TD, Recordon-Pinson P, Minga A, Ekouevi D, Bonard D, Bequet L, Huet C, Chenal H, Rouet F, Dabis F, Lafon ME, Salamon R, Masquelier B, Fleury HJ. Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Côte d'Ivoire: ANRS 1257 study. Aids Research and Human Retroviruses. 19: 713-7. PMID 14506786 DOI: 10.1089/088922203322280946  0.044
2011 Ribeyre X, Tikhonchuk VT, Breil J, Lafon M, Le Bel E. Analytic criteria for shock ignition of fusion reactions in a central hot spot Physics of Plasmas. 18. DOI: 10.1063/1.3646743  0.044
2011 Cecchetti CA, Giulietti A, Koester P, Labate L, Levato T, Gizzi LA, Antonelli L, Patria A, Batani D, Kozlová M, Margarone D, Nejdl J, Rus B, Sawicka M, Lafon M, et al. Parametric instabilities study in a shock ignition relevant regime Proceedings of Spie - the International Society For Optical Engineering. 8080. DOI: 10.1117/12.891249  0.043
2013 Ribeyre X, Tikhonchuk VT, Breil J, Lafon M, Vallet A, Bel EL. Analytical criterion for shock ignition of fusion reaction in hot spot Epj Web of Conferences. 59. DOI: 10.1051/epjconf/20135903005  0.043
1999 Nguyen TH, Masquelier B, Pham VH, Nguyen TV, Lafon ME, Truong TX, Nguyen HC, Sinoussi FB, Fleury HJ. Further characterization of HIV-1 isolates from Ho Chi Minh City, Vietnam. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 20: 93-5. PMID 9928736  0.043
2010 Faure-Della Corte M, Samot J, Garrigue I, Magnin N, Reigadas S, Couzi L, Dromer C, Velly JF, Déchanet-Merville J, Fleury HJ, Lafon ME. Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 47: 161-9. PMID 20022297 DOI: 10.1016/j.jcv.2009.11.023  0.043
2002 Schvoerer E, Kabissa I, Cotto E, Jouvencel AC, Balabaud C, De Ledinghen V, Couzigou P, Quinton A, Schvoerer C, Lafon ME, Fleury H, Bernard PH. Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients. Gastroentã©Rologie Clinique Et Biologique. 26: 62-6. PMID 11938042  0.042
2007 Garrigue I, Corte MF, Magnin N, Couzi L, Capdepont S, Rio C, Merville P, Dechanet-Merville J, Fleury H, Lafon ME. Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 40: 120-8. PMID 17827058 DOI: 10.1016/j.jcv.2007.06.015  0.041
1950 LAFON M. [Utilization of vitelline reserves during embryogeny; performed on an insect: Carausius (Dixippus) morosus]. Archives Internationales De Physiologie. 57: 309-42. PMID 15414033  0.041
2001 Caumont A, Lan NT, Uyen NT, Hung PV, Schvoerer E, Urriza MS, Roques P, Schrive MH, Lien TT, Lafon ME, Dormont D, Barre-Sinoussi F, Fleury HJ. Sequence analysis of env C2/V3, gag p17/p24, and pol protease regions of 25 HIV type 1 isolates from Ho Chi Minh City, Vietnam. Aids Research and Human Retroviruses. 17: 1285-91. PMID 11559429 DOI: 10.1089/088922201750461357  0.041
2007 Castéra L, Loko MA, Le Bail B, Coffie P, De Ledinghen V, Trimoulet P, Winnock M, Dabis F, Neau D, Chêne G, Dupon M, Longy-Boursier M, Morlat P, Pellegrin JL, Ragnaud JM, ... ... Lafon ME, et al. Hepatic steatosis in HIV-HCV coinfected patients in France: Comparison with HCV monoinfected patients matched for body mass index and HCV genotype Alimentary Pharmacology and Therapeutics. 26: 1489-1498. PMID 17903235 DOI: 10.1111/J.1365-2036.2007.03533.X  0.039
2010 Schurtz G, Ribeyre X, Lafon M. Target design for shock ignition Journal of Physics: Conference Series. 244. DOI: 10.1088/1742-6596/244/2/022013  0.039
1954 MORIN M, LAFON MJ, GRAVELEAU J, COLONNA D, ACAR J, LAPLANE D. [Eight cases of Kahler's disease; therapeutic remarks]. La Semaine Des Hã´Pitaux : Organe Fondã© Par L'Association D'Enseignement Mã©Dical Des Hã´Pitaux De Paris. 30: 3989-4002. PMID 13225794  0.039
2013 Lafon M. Immunology Rabies. 387-408. DOI: 10.1016/B978-0-12-396547-9.00010-9  0.039
2009 Ribeyre X, Lafon M, Schurtz G, Olazabal-Loumé M, Breil J, Galera S, Weber S. Shock ignition: Modelling and target design robustness Plasma Physics and Controlled Fusion. 51. DOI: 10.1088/0741-3335/51/12/124030  0.038
1985 Lafon M, Perrin P, Versmisse P, Sureau P. Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay. Journal of Biological Standardization. 13: 295-301. PMID 3902842  0.038
1990 Bioulac-Sage P, Lafon ME, Saric J, Balabaud C. Nerves and perisinusoidal cells in human liver. Journal of Hepatology. 10: 105-12. PMID 2407769  0.037
1988 Lafon ME, Bioulac-Sage P, Balabaud C. Hepatic fibrosis in patients with idiopathic thrombocytopenic purpura. Liver. 8: 24-7. PMID 3367705  0.035
1985 Perrin P, Lafon M, Versmisse P, Sureau P. [Application of an immunoenzyme method to the titration of neutralized rabies antibodies in cell culture]. Journal of Biological Standardization. 13: 35-42. PMID 3886664  0.034
1996 Menu E, Truong TX, Lafon ME, Nguyen TH, Müller-Trutwin MC, Nguyen TT, Deslandres A, Chaouat G, Duong QT, Ha BK, Fleury HJ, Barré-Sinoussi F. HIV type 1 Thai subtype E is predominant in South Vietnam. Aids Research and Human Retroviruses. 12: 629-33. PMID 8743088  0.033
2004 Deshpande A, Recordon-Pinson P, Deshmukh R, Faure M, Jauvin V, Garrigue I, Lafon ME, Fleury HJ. Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations. Aids Research and Human Retroviruses. 20: 1032-5. PMID 15585093 DOI: 10.1089/0889222042222782  0.033
2012 Theobald W, Nora R, Lafon M, Casner A, Ribeyre X, Anderson KS, Betti R, Delettrez JA, Frenje JA, Glebov VY, Gotchev OV, Hohenberger M, Hu SX, Marshall FJ, Meyerhofer DD, et al. Spherical shock-ignition experiments with the 40 20-beam configuration on OMEGA Physics of Plasmas. 19. DOI: 10.1063/1.4763556  0.033
1991 Winnock M, Lafon ME, Boulard A, Ferrer AM, Saric J, Dubuisson L, Bioulac-Sage P, Balabaud C. Characterization of liver-associated natural killer cells in patients with liver tumors. Hepatology (Baltimore, Md.). 13: 676-82. PMID 2010163  0.032
2008 Bréhin AC, Mouriès J, Frenkiel MP, Dadaglio G, Desprès P, Lafon M, Couderc T. Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population. Journal of Immunology (Baltimore, Md. : 1950). 180: 6760-7. PMID 18453596  0.032
2010 Lafon M, Ribeyre X, Schurtz G. Gain curves and hydrodynamic modeling for shock ignition Physics of Plasmas. 17. DOI: 10.1063/1.3407623  0.031
2014 Vareil MO, Rouibi G, Kassab S, Soula V, Duffau P, Lafon ME, Neau D, Cazanave C. Epidemic of complicated mumps in previously vaccinated young adults in the South-West of France. MéDecine Et Maladies Infectieuses. 44: 502-8. PMID 25391635 DOI: 10.1016/j.medmal.2014.09.006  0.031
2010 Rosenberg LC, Lafon ML, Pedersen JK, Yassin H, Jensen JN, Serup P, Hecksher-Sørensen J. The transcriptional activity of Neurog3 affects migration and differentiation of ectopic endocrine cells in chicken endoderm. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 239: 1950-66. PMID 20549731 DOI: 10.1002/dvdy.22329  0.031
1986 Vodopija I, Sureau P, Lafon M, Baklaic Z, Ljubicić M, Svjetlicić M, Smerdel S. An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule. Vaccine. 4: 245-8. PMID 3541428  0.03
1951 LAFON M. [Some information on appetite and food consumption in insects]. Annales De La Nutrition Et De L'Alimentation. 5: 485-504. PMID 14924351  0.029
2007 Viallard JF, Lazaro E, Ellie E, Eimer S, Camou F, Caubet O, Lafon ME, Fleury H, Pellegrin JL. Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis. Infection. 35: 33-6. PMID 17297588 DOI: 10.1007/s15010-006-5103-y  0.029
2012 Couzi L, Helou S, Bachelet T, Martin S, Moreau K, Morel D, Lafon ME, Garrigue I, Merville P. Preemptive therapy versus valgancyclovir prophylaxis in cytomegalovirus-positive kidney transplant recipients receiving antithymocyte globulin induction. Transplantation Proceedings. 44: 2809-13. PMID 23146529 DOI: 10.1016/j.transproceed.2012.09.029  0.029
2005 Viallard JF, Lazaro E, Lafon ME, Pellegrin JL. Successful cidofovir therapy of progressive multifocal leukoencephalopathy preceding angioimmunoblastic T-cell lymphoma. Leukemia & Lymphoma. 46: 1659-62. PMID 16334909 DOI: 10.1080/10428190500177995  0.028
2011 Nejdl J, Kozlová M, Sawicka M, Margarone D, Krus M, Prokupek J, Rus B, Batani D, Antonelli L, Patria A, Ciricosta O, Cecchetti C, Koester P, Labate L, Giulietti A, ... ... Lafon M, et al. Investigation of laser plasmas relevant to shock ignition at PALS Proceedings of Spie - the International Society For Optical Engineering. 8080. DOI: 10.1117/12.892321  0.028
1996 Lafon M, Galelli A. Superantigen related to rabies. Springer Seminars in Immunopathology. 17: 307-18. PMID 8966658  0.028
1996 Astoul E, Lafage M, Lafon M. Rabies superantigen as a Vbeta T-dependent adjuvant. The Journal of Experimental Medicine. 183: 1623-31. PMID 8666920  0.028
1952 RIBEREAU-GAYON J, PEYNAUD E, LAFON M. [Action of an activator of alcoholic fermentation produced by Aspergillus niger on the balance of secondary products]. Comptes Rendus Hebdomadaires Des Sã©Ances De L'Acadã©Mie Des Sciences. 234: 757-9. PMID 12979231  0.027
2014 Khan Z, Lafon M. PDZ domain-mediated protein interactions: therapeutic targets in neurological disorders. Current Medicinal Chemistry. 21: 2632-41. PMID 24606518  0.027
1990 Perrin P, Lafon M, Sureau P. Rabies vaccines from Pasteur's time up to experimental subunit vaccines today. Advances in Biotechnological Processes. 14: 325-45. PMID 2222836  0.026
1994 Lafon M. Immunobiology of lyssaviruses: the basis for immunoprotection. Current Topics in Microbiology and Immunology. 187: 145-60. PMID 7532121  0.026
2000 Coustou D, Masquelier B, Lafon ME, Labrèze C, Roul S, Bioulac-Sage P, Mégraud F, Fleury HJ, Taïeb A. Asymmetric periflexural exanthem of childhood: microbiologic case-control study. Pediatric Dermatology. 17: 169-73. PMID 10886745  0.026
1988 Bourhy H, Lafon M, Berthonneau MC, Renner Y, Rollin PE, Sureau P. Rabies in vaccinated dogs in Gabon. The Veterinary Record. 122: 361-2. PMID 3381454  0.026
2013 Anderson KS, Betti R, McKenty PW, Collins TJB, Hohenberger M, Theobald W, Craxton RS, Delettrez JA, Lafon M, Marozas JA, Nora R, Skupsky S, Shvydky A. A polar-drive shock-ignition design for the National Ignition Facility Physics of Plasmas. 20. DOI: 10.1063/1.4804635  0.024
1977 Watelet VF, Leclerc D, Lafon M. [Comparative anatomical result of conservative treatment and surgery in severe recent sprains of the ankle (author's transl)]. Journal De Chirurgie. 114: 287-92. PMID 591592  0.024
2000 Pastor J, Lafon M, Travé-Massuyès L, Démonet JF, Doyon B, Celsis P. Information processing in large-scale cerebral networks: the causal connectivity approach. Biological Cybernetics. 82: 49-59. PMID 10650907  0.024
1987 Lafon ME, Bioulac-Sage P, Grimaud JA, Boussarie L, Merlio JP, Reiffers J, Balabaud C. Perisinusoidal fibrosis of the liver in patients with thrombocytopenic purpura. Virchows Archiv. a, Pathological Anatomy and Histopathology. 411: 553-9. PMID 3118564  0.024
2006 Lafon MO, Trannoy M. Influence of drying temperature on the morphology of latex at the surface of pigments - Consequences on the paper properties 2006 Tappi Advanced Coating Fundamentals Symposium. 2006: 286-294.  0.024
2012 Couzi L, Helou S, Bachelet T, Moreau K, Martin S, Morel D, Lafon ME, Boyer B, Alain S, Garrigue I, Merville P. High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapy. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 12: 202-9. PMID 21967659 DOI: 10.1111/j.1600-6143.2011.03766.x  0.023
2009 Ribeyre X, Schurtz G, Lafon M, Galera S, Weber S. Shock ignition: An alternative scheme for HiPER Plasma Physics and Controlled Fusion. 51. DOI: 10.1088/0741-3335/51/1/015013  0.023
2000 Pellegrin I, Garrigue I, Ekouevi D, Couzi L, Merville P, Merel P, Chene G, Schrive MH, Trimoulet P, Lafon ME, Fleury H. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients. The Journal of Infectious Diseases. 182: 36-42. PMID 10882579 DOI: 10.1086/315688  0.022
2013 Lafon M, Ribeyre X, Schurtz G, Le Bel E. Hydrodynamic modeling and simulations of shock ignition thresholds Epj Web of Conferences. 59. DOI: 10.1051/epjconf/20135903002  0.022
2004 Dutronc H, Dupon M, Cipriano G, Lafarie S, Lafon ME, Fleury HJ, Bocquentin F, Neau D, Ragnaud JM. [Severe acute respiratory syndrome: one case of indirect transmission by Coronavirus]. La Revue De Mã©Decine Interne / Fondã©E ... Par La Sociã©Tã© Nationale Francaise De Mã©Decine Interne. 25: 607-9. PMID 15276297 DOI: 10.1016/j.revmed.2004.05.001  0.022
2005 Schvoerer E, Lafon ME. 2nd European Congress of Virology and Eurovirology 2004 | 2nd European Congress of Virology Eurovirology 2004 Virologie. 9: 238-242.  0.021
2009 Lafon M. Art by the ground Soil and Culture. 147-165. DOI: 10.1007/978-90-481-2960-7_10  0.021
2005 Capdepont S, Londos-Gagliardi D, Joubert M, Correze P, Lafon ME, Guillemain B, Fleury HJ. New insights in HTLV-I phylogeny by sequencing and analyzing the entire envelope gene. Aids Research and Human Retroviruses. 21: 28-42. PMID 15665642 DOI: 10.1089/aid.2005.21.28  0.02
1958 RIBEREAU-GAYON J, PEYNAUD E, LAFOURCADE S, LAFON M. [Mode of action of antifungal antibiotics on yeasts]. Bulletin De La Sociã©Tã© De Chimie Biologique. 40: 189-201. PMID 13546854  0.02
1960 LAFON M. [Some aspects of dehydration of the organism during development: biochemical observations in the rabbit and the rat]. Archives Internationales De Physiologie Et De Biochimie. 68: 460-77. PMID 14413401  0.019
1949 ROCHE J, LAFON M. [Not Available]. Comptes Rendus Hebdomadaires Des Sã©Ances De L'Acadã©Mie Des Sciences. 229: 481. PMID 18141610  0.018
1948 LAFON M, MAYOL F. [Not Available]. Comptes Rendus Des SéAnces De La SociéTé De Biologie Et De Ses Filiales. 142: 360-2. PMID 18878692  0.018
1947 ROCHE J, MICHEL R, LAFON M. [Not Available]. Comptes Rendus Des Sã©Ances De La Sociã©Tã© De Biologie Et De Ses Filiales. 141: 301-3. PMID 20262556  0.018
1947 ROCHE J, MICHEL R, LAFON M. [Not Available]. Comptes Rendus Hebdomadaires Des Sã©Ances De L'Acadã©Mie Des Sciences. 224: 1242-4. PMID 20256084  0.018
1947 ROCHE J, MICHEL R, LAFON M. [Not Available]. Comptes Rendus Hebdomadaires Des Sã©Ances De L'Acadã©Mie Des Sciences. 224: 233-5. PMID 20256025  0.018
1947 LAFON M. [Not Available]. Archives Internationales De Physiologie. 55: 123-52. PMID 18920601  0.018
1945 MICHEL R, LAFON M. [Not available]. Bulletin De La Sociã©Tã© De Chimie Biologique. 27: 644-6. PMID 21027607  0.018
2010 Lafon M, Van Hook AM. Science signaling podcast: 26 January 2010 Science Signaling. 3: pc2. DOI: 10.1126/Scisignal.3106Pc2  0.017
1998 Garenne M, Lafon M. Sexist diseases. Perspectives in Biology and Medicine. 41: 176-89. PMID 9493399  0.017
1990 Ceballos I, Lafon M, Javoy-Agid F, Hirsch E, Nicole A, Sinet PM, Agid Y. Superoxide dismutase and Parkinson's disease. Lancet. 335: 1035-6. PMID 1970085 DOI: 10.1016/0140-6736(90)91099-V  0.015
2010 Brun JL, Randriambelomanana J, Cherier L, Lafon ME, Trufflandier N, Le Bail B. Lymphoepithelioma-like carcinoma of the ovary: a case report and review of the literature. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 29: 427-31. PMID 20736767 DOI: 10.1097/PGP.0b013e3181db69da  0.015
1956 GENEVOIS L, LAFON M. [Transformation of labeled acetate by yeast during anaerobic fermentation; formation of succinic acid, isopropanol, amyl alcohol and sterols]. Bulletin De La Sociã©Tã© De Chimie Biologique. 38: 89-97. PMID 13329638  0.015
2001 Schvoerer E, Ventura M, Dubos O, Cazaux G, Serceau R, Gournier N, Dubois V, Caminade P, Fleury HJ, Lafon ME. Qualitative and quantitative molecular detection of enteroviruses in water from bathing areas and from a sewage treatment plant. Research in Microbiology. 152: 179-86. PMID 11316372  0.015
2011 Jacquemot S, Amiranoff F, Baton SD, Chanteloup JC, Labaune C, Koenig M, Michel DT, Perez F, Schlenvoigt HP, Canaud B, Cherfils Clérouin C, Debras G, Depierreux S, Ebrardt J, Juraszek D, ... ... Lafon M, et al. Studying ignition schemes on European laser facilities Nuclear Fusion. 51. DOI: 10.1088/0029-5515/51/9/094025  0.014
1969 Blanc B, Lafon M, Olmer M, Piana L, Sudan JP, Tronconi JC, Olivier G. [4 cases of recurring jaundice in pregnancy]. Bulletin De La Fã©Dã©Ration Des Sociã©Tã©S De Gynã©Cologie Et Dã³Bstã©Trique De Langue Franã§Aise. 21: 190-4. PMID 5399119  0.014
2008 Ribeyre X, Schurtz G, Lafon M, Weber S. Bipolar shock ignition: An option for the HiPER project 35th Eps Conference On Plasma Physics 2008, Eps 2008 - Europhysics Conference Abstracts. 32: 1691-1694.  0.013
1953 LAFON M. [Certain data on water and mineral equilibrium and its regulation in invertebrates]. Archives Des Sciences Physiologiques. 7: C 39-53. PMID 13149334  0.012
1952 BLANC M, D'AULNAY J, AUSSARESSES, LAFON MR. [Reflections on two years' practice in pediatric medico-psychological]. Journal De Mã©Decine De Bordeaux Et Du Sud-Ouest. 129: 668-74. PMID 13023142  0.011
2014 Durette B, Fournier M, Lafon M. The core competencies of PhDs Studies in Higher Education. DOI: 10.1080/03075079.2014.968540  0.011
2012 Ermolli I, Bettonvil F, Cauzzi G, Cavaller L, Collados M, Di Marcantonio P, Grivel C, Paletou F, Romano P, Aboudarham J, Cirami R, Cosentino R, Giorgi F, Lafon M, Laforgue D, et al. Data handling and control of the European solar telescope Memorie Della Societa Astronomica Italiana - Journal of the Italian Astronomical Society. 19: 380-383.  0.01
2011 Antonelli L, Batani D, Patria A, Ciricosta O, Cecchetti CA, Koester P, Labate L, Giulietti A, Gizzi LA, Moretti A, Richetta M, Giuffrida L, Torrisi L, Kozlová M, Nejdl J, ... ... Lafon M, et al. Laser-plasma coupling in the shock-ignition intensity regime Acta Technica Csav (Ceskoslovensk Akademie Ved). 56: T57-T69.  0.01
2010 Ermolli I, Bettonvil F, Cauzzi G, Cavaller L, Collados M, Di Marcantonio P, Paletou F, Romano P, Aboudarham J, Cirami R, Cosentino R, Giorgi F, Lafon M, Laforgue D, Reardon K, et al. Data handling and control for the European Solar Telescope Proceedings of Spie - the International Society For Optical Engineering. 7740. DOI: 10.1117/12.856938  0.01
2010 Webb V, Lafon M, Pare P. Bantu languages in education in South Africa: An overview. Ongekho akekho! - the absentee owner Language Learning Journal. 38: 273-292. DOI: 10.1080/09571730903208389  0.01
1987 Lafon ME, Bioulac-Sage P, Longy M, Perez E, De Mascarel A, Grimaud JA, Balabaud C. [Perisinusoidal fibrosis in idiopathic thrombopenic purpura]. Gastroentã©Rologie Clinique Et Biologique. 11: 510-3. PMID 3609647  0.01
1979 Bazot M, Lafargue P, Lafon M, Guilbaud J. [Suicidal behavior and serum creatine kinase activity]. Annales Mã©Dico-Psychologiques. 137: 114-20. PMID 507579  0.01
1961 BARAUD J, GENEVOIS L, LAFON M. [Synthesis of isobutanol and amyl alcohols by yeast in anaerobiosis at the expense of alanine]. Comptes Rendus Hebdomadaires Des Sã©Ances De L'Acadã©Mie Des Sciences. 253: 562-3. PMID 13864793  0.01
1956 LAFON M. [Various biochemical and physiological properties of wine yeasts]. Annales De L'Institut Pasteur. 91: 91-9. PMID 13340334  0.01
1955 RIBEREAU-GAYON J, PEYNAUD E, LAFON M. [Research on the formation of secondary products in alcoholic fermentation]. Bulletin De La Sociã©Tã© De Chimie Biologique. 37: 457-73. PMID 13250311  0.01
1954 LAFON M. [Secondary products in alkaline fermentation]. Comptes Rendus Hebdomadaires Des Sã©Ances De L'Acadã©Mie Des Sciences. 238: 847-9. PMID 13150609  0.01
1951 LAFON MR. [Problem of peduncular hallucinosis]. Paris Mã©Dical. 41: 181-8. PMID 14853559  0.01
Hide low-probability matches.